X. -. Liu

发表

Characterization of [125I-Tyr0]-corticotropin releasing factor (CRF) binding to the CRF binding protein using a scintillation proximity assay

N. Ling, S. D. Kahl, D. Gehlert, 1998, Journal of Neuroscience Methods.

Expression and characterization of a putative high affinity human soluble leptin receptor.

N. Ling, R. Maki, E. D. De Souza, 1997, Endocrinology.

The heparin binding site of follistatin is involved in its interaction with activin.

N. Ling, S. Inouye, S. Shimasaki, 1995, Biochemical and biophysical research communications.

Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

N. Ling, E. D. De Souza, Xin-jun Liu, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells.

N. Ling, M. Malkowski, Xin-jun Liu, 1993, Endocrinology.

Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2).

R. Maki, T. Lovenberg, E. D. De Souza, 1996, Journal of neuroimmunology.

Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay.

N. Ling, E. D. De Souza, R. Goland, 1996, The Journal of clinical endocrinology and metabolism.

Selective Impairment of Corticotropin-Releasing Factor1 (CRF1) Receptor-Mediated Function Using CRF Coupled to Saporin1.

N. Ling, S. Heinrichs, D. Grigoriadis, 2000, Endocrinology.

Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy.

N. Ling, A. Gaur, E. D. De Souza, 1997, Cellular immunology.

Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain

N. Ling, S. D. Kahl, D. Gehlert, 1999, Neuroscience.

Structural and functional studies of insulin-like growth factor binding proteins in the ovary.

N. Ling, Nicholas Ling, M. Malkowski, 1993, Growth regulation.

Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.

N. Ling, Q. Xie, X. -. Liu, 2001, Journal of medicinal chemistry.

Identification of a Nonpeptide Ligand That Releases Bioactive Insulin-like Growth Factor-I from Its Binding Protein Complex*

N. Ling, Q. Xie, Chen Chen, 2001, The Journal of Biological Chemistry.

Extrapituitary actions of gonadotropin-releasing hormone: stimulation of insulin-like growth factor-binding protein-4 and atresia.

N. Ling, S. Shimasaki, G. Erickson, 1994, Endocrinology.

Regulation of IGFBP-4 and -5 expression in rat granulosa cells.

N. Ling, X. -. Liu, 1993, Advances in experimental medicine and biology.

125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.

N. Ling, E. D. De Souza, W. Vale, 1996, Molecular pharmacology.

Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.

N. Ling, R. Maki, E. D. De Souza, 1999, Gene.